Lexeo Therapeutics (LXEO) Invested Capital (2022 - 2023)
Historic Invested Capital for Lexeo Therapeutics (LXEO) over the last 2 years, with Q3 2023 value amounting to -$162.8 million.
- Lexeo Therapeutics' Invested Capital fell 6448.91% to -$162.8 million in Q3 2023 from the same period last year, while for Sep 2023 it was -$162.8 million, marking a year-over-year decrease of 6448.91%. This contributed to the annual value of -$113.0 million for FY2022, which is N/A changed from last year.
- As of Q3 2023, Lexeo Therapeutics' Invested Capital stood at -$162.8 million, which was down 6448.91% from -$113.0 million recorded in Q4 2022.
- In the past 5 years, Lexeo Therapeutics' Invested Capital registered a high of -$99.0 million during Q3 2022, and its lowest value of -$162.8 million during Q3 2023.